Funding
ALV
BRAIN TUMOR
The clinical trial in this work was sponsored and funded by StemGen Spa, a biotech company based in Milan, Italy. This work was supported by the following grants to ALV: a grant from “Associazione Italiana Cancro” (IG-22027); a Grant from the James S. McDonnel Foundation (USA); a Grant From the Brain Tumor Funders Collaborative Initiative (USA); A grant from “Regione Lombardia (Italy). A grant “Ministero della Salute Italiano” (GR-2011- 02351534 and Progetto Ricerca Corrente 2018–20) to EB also supported this study. Part of this work was supported by Erasmus MC via departmental (Cell Biology) and BIG project funding (together with Erasmus University Rotterdam).